Subsequently, we sought to elucidate the relationship between MVP expression and ICI (immune checkpoint inhibitor) therapy, an emerging paradigm in pancreatic carcinoma treatment (20). The gene discussed is MVP; the disease is exocrine pancreatic carcinoma.